The U.S. Food and Drug Administration (FDA) has recently revealed its plans to postpone the enforcement of specific requirements under the Modernization of Cosmetics Regulation Act (MoCRA) of 2022. The regulations in question pertain to the registration of cosmetic product facilities and product listing.
Certain MoCRA requirements were expected to be rigorously enforced as a part of the FDA’s strategy to modernize and strengthen the regulation of cosmetic products. However, the recent announcement indicates a change of plans, temporarily easing the regulatory burden on the cosmetic industry.
Apparently, corporations and law firms working in the cosmetic industry are expected to benefit greatly from this delay, providing them additional time to review and comply with the new regulatory requirements.
Additional information on this topic can be found in the full article provided by Shook, Hardy & Bacon L.L.P., on JD Supra’s website. To read more about FDA’s decision, click here.
The reasons behind the FDA’s move towards postponing the enforcement of certain provisions of the MoCRA are unclear at this point. However, it’s essential for professionals in the field to keep tabs on the FDA’s policy updates and actions regarding the enforcement of MoCRA requirements. This will not only be crucial for maintaining compliance but also for successfully navigating the intricate landscape of cosmetic regulations in the future.
Stay tuned for follow-ups on this topic, as well as additional insights into FDA’s ongoing regulatory adjustments within the cosmetics industry.